🎯INCA equips NET patients with NET #clinicaltrials knowledge and data across the globe.
✅Check out our website for insightful guidance form prominent NET experts and search for the clinical trial that fits your condition: https://t.co/WTim4QjYEf
#LetsTalkAboutNETs#EndoTwitter
Dr. Gerlof Valk @UMCUtrecht illustrates the shocking heterogeneity of neuroendocrine tumors, presenting near-identical cases at time of diagnosis with rapidly divergent outcomes after PRRT
A true unmet need in oncology is image-guided precision medicine
#WorldMEN2023
@DerksJules showing how the molecular subtypes in lung #NETs as defined by @nl_alcala can be easily identified and their impact in clinical practice. Let’s keep translating basic research as quickly as possible thanks to collaborations initiated at #ENETS2023!
#EuropeanHormoneDay is back! On 15 May we invite you to join us in raising awareness of the importance of good hormone health + promote better policies for endocrine patients. Follow using #BecauseHormonesMatter + visit https://t.co/cPxfMbeNjs for details.
👉Opportunity for HCPs to get updates on generic syndromes in NEN:
✅Check out the ENETS webinar on April 19th: https://t.co/RnvDsT9vUo
ENETS webinars are free of charge and videos are available on the website.
#LetsTalkAboutNETs#EndoTwitter#OncTwitter#MedTwitter
De incidentie van #neuroendocrienekanker is in 30 jaar meer dan ver4voudigd. Oorzaken vaak te laat gestelde diagnose: weinig bekende tumoren, vage klachten, sluipende ontwikkeling vd kanker. Dat vraagt specifieke aanpak en behandeling. #SamenZeldzaam@netcancerday@rarediseaseday
Beleidsvoerder, onderzoeker, laborant, apotheker, verpleger, arts-specialist, huisarts, chirurg, radioloog, … HOOR ONS, WERELDWIJD!
NEN en àlle zeldzame kankers uit de schaduwzone halen, samen werken we er aan. #SamenZeldzaam#neuroendocrienekanker@netcancerday@rarediseaseday
INCA Executive Director @TeodoraINCA, one of the #CancerGroundshot authors: It is only by putting patient-focused research at the heart of a pan-European cancer strategy that we can drive enhanced health outcomes. Highlights and data: https://t.co/qDr2WV81vM @EuropeanCancer